Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses
Authors
Keywords
-
Journal
Journal of Hematology & Oncology
Volume 15, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-04-29
DOI
10.1186/s13045-022-01266-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
- (2021) Eryn Blass et al. Nature Reviews Clinical Oncology
- Exosomes for mRNA delivery: a novel biotherapeutic strategy with hurdles and hope
- (2021) Cynthia Aslan et al. BMC BIOTECHNOLOGY
- Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma
- (2020) Ann-Lii Cheng et al. JOURNAL OF HEPATOLOGY
- Targeting Neoantigens in Hepatocellular Carcinoma for Immunotherapy: A Futile Strategy?
- (2020) Ligong Lu et al. HEPATOLOGY
- Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity
- (2020) Junyun Lai et al. NATURE IMMUNOLOGY
- Alarmin-painted exosomes elicit persistent antitumor immunity in large established tumors in mice
- (2020) Bingfeng Zuo et al. Nature Communications
- Cross-Presentation of Tumor Antigens Is Ruled by Synaptic Transfer of Vesicles among Dendritic Cell Subsets
- (2020) Sreekumar Balan et al. CANCER CELL
- A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
- (2020) Patrick A. Ott et al. CELL
- The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma
- (2020) Matthias Pinter et al. JAMA Oncology
- Dexosomes as a cell-free vaccine for cancer immunotherapy
- (2020) Sepideh Nikfarjam et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting natural killer cells in solid tumors
- (2019) Guillaume Habif et al. Cellular & Molecular Immunology
- Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination
- (2019) Linda Hammerich et al. NATURE MEDICINE
- Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma
- (2019) Markus W. Löffler et al. Genome Medicine
- Immunotherapy for hepatocellular carcinoma: Current and future
- (2019) Michael P Johnston et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment
- (2019) Monica Marzagalli et al. SEMINARS IN CANCER BIOLOGY
- Fluorescent peptide highlights micronodules in murine hepatocellular carcinoma models and humans in vitro
- (2018) Renwei Jing et al. HEPATOLOGY
- A facile approach to enhance antigen response for personalized cancer vaccination
- (2018) Aileen Weiwei Li et al. NATURE MATERIALS
- Anchor peptide captures, targets, and loads exosomes of diverse origins for diagnostics and therapy
- (2018) Xianjun Gao et al. Science Translational Medicine
- Innate Lymphoid Cells: 10 Years On
- (2018) Eric Vivier et al. CELL
- Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models
- (2017) Zhen Lu et al. JOURNAL OF HEPATOLOGY
- Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy
- (2017) Guizhi Zhu et al. Nature Communications
- Critical Role for CD103 + /CD141 + Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma
- (2016) Edward W. Roberts et al. CANCER CELL
- Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region
- (2016) Ran Xu Zhu et al. Gut and Liver
- Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humansin vitro
- (2016) Quan Rao et al. HEPATOLOGY
- Expansion and Activation of CD103 + Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
- (2016) Hélène Salmon et al. IMMUNITY
- Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
- (2016) Kelly D Moynihan et al. NATURE MEDICINE
- Dendritic Cells and Cancer Immunity
- (2016) Alycia Gardner et al. TRENDS IN IMMUNOLOGY
- Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers
- (2015) N Anandasabapathy et al. BONE MARROW TRANSPLANTATION
- Differential uptake and cross-presentation of soluble and necrotic cell antigen by human DC subsets
- (2015) Meng-Chieh Chiang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Mutant MHC class II epitopes drive therapeutic immune responses to cancer
- (2015) Sebastian Kreiter et al. NATURE
- Effect of tumor cells and tumor microenvironment on NK-cell function
- (2014) Massimo Vitale et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
- (2013) Miriam Merad et al. Annual Review of Immunology
- Epitope-optimized alpha-fetoprotein genetic vaccines prevent carcinogen-induced murine autochthonous hepatocellular carcinoma
- (2013) Yuan Hong et al. HEPATOLOGY
- Identification of an H2-Kb or H2-Db restricted and glypican-3-derived cytotoxic T-lymphocyte epitope peptide
- (2013) TATSUAKI IWAMA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- High-mobility group nucleosome-binding protein 1 acts as an alarmin and is critical for lipopolysaccharide-induced immune responses
- (2011) De Yang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Instructive cytokine signals in dendritic cell lineage commitment
- (2010) Michael A. Schmid et al. IMMUNOLOGICAL REVIEWS
- Origin and development of dendritic cells
- (2010) Kang Liu et al. IMMUNOLOGICAL REVIEWS
- Peripheral CD103+dendritic cells form a unified subset developmentally related to CD8α+conventional dendritic cells
- (2010) Brian T. Edelson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Updated Technology to Produce Highly Immunogenic Dendritic Cell-derived Exosomes of Clinical Grade
- (2010) Sophie Viaud et al. JOURNAL OF IMMUNOTHERAPY
- Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity
- (2008) K. Hildner et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now